ERA
0.003
50%
CNJ
0.02
-73.7%
M2R
0.003
50%
NAE
0.002
-33.3%
RAD
0.027
50%
RKB
0.003
-25%
MEM
0.004
33.3%
TAR
0.018
-25%
VKA
0.009
28.6%
OEL
0.004
-20%
RDN
0.005
25%
CPN
0.088
-16.2%
HAW
0.097
21.3%
TDO
0.145
-14.7%
DRO
2.7
17.4%
AX8
0.006
-14.3%
TEM
0.007
16.7%
ECS
0.006
-14.3%
4DX
2.845
16.6%
SER
0.006
-14.3%
CMA
1.98
16.1%
FCT
0.007
-12.5%
AMU
0.15
15.4%
PL9
0.007
-12.5%
RC1
0.098
15.3%
SRJ
0.014
-12.5%
BKB
0.79
13.7%
D3E
0.305
-11.6%
EOS
7.31
13.2%
NOX
0.088
-11.1%
EVR
0.009
12.5%
VRC
0.008
-11.1%
CLX
2.13
12.1%
WHK
0.008
-11.1%
AGR
0.02
11.1%
AUG
0.034
-10.5%
IMI
0.01
11.1%
ADG
0.009
-10%
SNX
0.03
11.1%
LMG
0.018
-10%
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

Control Bionics (ASX:CBL): Expands global reach with exclusive UK and Ireland distribution agreement

Control Bionics (ASX:CBL) expands global reach with exclusive UK and Ireland distribution agreement.

• Exclusive distribution of NeuroNode® by Smart Box in the UK and Ireland.
• Access to Smart Box’s established network of healthcare professionals and end-users.
• Strengthening Control Bionics’ presence in the European market.

Jeremy Steele, CEO of Control Bionics, commented: “The NeuroNode® has already been paired with hundreds of Smart Box
devices and devices with Smart Box software around the world.”

Read the ASX announcement ⚡ https://announcements.asx.com.au/asxpdf/20240909/pdf/067np1hzgg2sbv.pdf